#1 out of 131506.25%
health10h ago
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
Cnbc.com and 3 more
- The FDA will hold a summer meeting to consider allowing compounding pharmacies to produce over a dozen unapproved peptide injections that have become popular with wellness influencers and celebrities.
- Health secretary RFK Jr. has publicly advocated looser rules for peptides, arguing personal benefit while critics warn of safety risks and market flood.
- Panel discussion aims to determine if seven peptides should be added to a list permitting safe pharmacy compounding, signaling a cautious regulatory pathway.
Vote 4








